Implementation of enhanced liver fibrosis testing in type 2 diabetes to improve detection of at-risk metabolic dysfunction-associated steatohepatitis to optimize hepatology referrals: a duke health analysis
Conferences
Furley, M; Kaminski, T; Wolf, Z; Boltyenkov, A; Dinani, A
Published in: JOURNAL OF HEPATOLOGY
May 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JOURNAL OF HEPATOLOGY
EISSN
1600-0641
ISSN
0168-8278
Publication Date
May 2026
Volume
84
Start / End Page
S580 / S580
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Furley, M., Kaminski, T., Wolf, Z., Boltyenkov, A., & Dinani, A. (2026). Implementation of enhanced liver fibrosis testing in type 2 diabetes to improve detection of at-risk metabolic dysfunction-associated steatohepatitis to optimize hepatology referrals: a duke health analysis. In JOURNAL OF HEPATOLOGY (Vol. 84, pp. S580–S580).
Furley, Maison, Tom Kaminski, Zach Wolf, Artem Boltyenkov, and Amreen Dinani. “Implementation of enhanced liver fibrosis testing in type 2 diabetes to improve detection of at-risk metabolic dysfunction-associated steatohepatitis to optimize hepatology referrals: a duke health analysis.” In JOURNAL OF HEPATOLOGY, 84:S580–S580, 2026.
Furley M, Kaminski T, Wolf Z, Boltyenkov A, Dinani A. Implementation of enhanced liver fibrosis testing in type 2 diabetes to improve detection of at-risk metabolic dysfunction-associated steatohepatitis to optimize hepatology referrals: a duke health analysis. In: JOURNAL OF HEPATOLOGY. 2026. p. S580–S580.
Furley, Maison, et al. “Implementation of enhanced liver fibrosis testing in type 2 diabetes to improve detection of at-risk metabolic dysfunction-associated steatohepatitis to optimize hepatology referrals: a duke health analysis.” JOURNAL OF HEPATOLOGY, vol. 84, 2026, pp. S580–S580.
Furley M, Kaminski T, Wolf Z, Boltyenkov A, Dinani A. Implementation of enhanced liver fibrosis testing in type 2 diabetes to improve detection of at-risk metabolic dysfunction-associated steatohepatitis to optimize hepatology referrals: a duke health analysis. JOURNAL OF HEPATOLOGY. 2026. p. S580–S580.
Published In
JOURNAL OF HEPATOLOGY
EISSN
1600-0641
ISSN
0168-8278
Publication Date
May 2026
Volume
84
Start / End Page
S580 / S580
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences